Normal view MARC view ISBD view

Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination.

Savasta, Salvatore

Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination. [electronic resource] - Neurology. Clinical practice Dec 2017 - 534-537 p. digital

Publication Type: Case Reports; Journal Article

ISSN: 2163-0402

Standard No.: 10.1212/CPJ.0000000000000388 doi

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)